National Health Act 1953 Determination under subsection 85B(1) (No. PB 8 of 2007) (Cth)

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DETERMINATION UNDER SUBSECTION 85B(1)

No. PB 8 of 2007

I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, pursuant to subsection 85B(1) of the National Health Act 1953, hereby make the following Determination:

1.   This Determination commences on 1 February 2007.

1. The Determination (No. PB 48 of 2006) under subsection 85B(1) of the National Health Act 1953 made on 7 November 2006 with effect from 1 December 2006, as amended on 1 December 2006 with effect from 1 January 2007 (No. PB 5 of 2007), is, in this Determination, referred to as the Principal Determination.

3.  The Schedule to the Principal Determination is amended by omitting the details in respect of the pharmaceutical benefit Pilocarpine Hydrochloride eye drops 5 mg per mL, 15 mL.

4.  The Schedule to the Principal Determination is amended by omitting the following details in respect of the pharmaceutical benefit Ramipril:

PART A		PART B			PART C		PART D
Drug or medicinal preparation		PHARMACEUTICAL BENEFIT			Relevant quantity or number of units			Manufac-turer's price for sales $		Price claimed by manu-facturer $
		Form (strength, type, size, etc)		Brand
Ramipril		Tablet 1.25 mg (unless supplied on an authority prescription)		AV ML			30 30	6.35 6.35		9.08 7.26
Tablet 2.5 mg (unless supplied on an authority prescription)		AV ML			30 30	9.28 9.28		12.01 10.61
Tablet 5 mg (unless supplied on an authority prescription)		AV ML			30 30	11.64 11.64		14.36 13.30
Capsule 10 mg (unless supplied on an authority prescription)		AV ML			30 30	20.54 20.54		23.47 23.47
Pack containing 7 tablets 2.5 mg, 21 tablets 5 mg and 10 capsules 10 mg (unless supplied on an authority prescription)		AV			1	18.09		20.67
Tablet 1.25 mg (if supplied on an authority prescription)		AV			30	7.26		9.08
Tablet 2.5 mg (if supplied on an authority prescription)		AV			30	10.61		12.01
Tablet 5 mg (if supplied on an authority prescription)		AV			30	13.30		14.36

and substituting:

PART A		PART B			PART C		PART D
Drug or medicinal preparation		PHARMACEUTICAL BENEFIT			Relevant quantity or number of units			Manufac-turer's price for sales $		Price claimed by manu-facturer $
		Form (strength, type, size, etc)		Brand
Ramipril		Tablet 1.25 mg		AV ML			30 30	6.35 6.35		9.08 7.26
Tablet 2.5 mg		AV ML			30 30	9.28 9.28		12.01 10.61
Tablet 5 mg		AV ML			30 30	11.64 11.64		14.36 13.30
Capsule 10 mg		AV ML			30 30	20.54 20.54		23.47 23.47
Pack containing 7 tablets 2.5 mg, 21 tablets 5 mg and 10 capsules 10 mg (unless supplied on an authority prescription)		AV			1	18.09		20.67

Dated this 5^th day of January 2007.

DIANA MACDONELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Delegate of the Minister for Health and Ageing